Atai Life Sciences
ATAI is an internationally active biotech company investing in and acquiring therapeutics focusing on longevity and mental wellbeing.
Total raised
€273M
€272,823,455
Funding rounds
3
Investors
4
distinct backers
Active since
2018-12
latest 2021-03
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood22
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▲ Up-round momentum
- ▼ Low backer re-investment
Exit likelihood24
base rate 12% (2+ rounds)
- ▲ 3 rounds raised
- ▲ €100M+ raised
- ▲ 8y since founding
Timing: dormant vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
3 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2021-03-03 | Series D+ | €130M | Apeiron Investment Group,Thiel Capital,Woodline Partners | View deal → |
| 2020-11-23 | Series C | €106M | — | View deal → |
| 2019-01-01 | Series B | €37M | Subversive Capital | View deal → |
Related news
Similar companies
same sector or country- Delivery Hero€7.3BGermany · E-commerce
- Enpal€4.6BGermany · Cleantech
- Auxmoney€3.5BGermany · Fintech
- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- Celonis€2.1BGermany · Software